A critical advance in cancer investigation is emerging with the use of VHH fragments to reactivate mutated p53. This vital tumor suppressor protein is frequently disabled in various kinds of malignancies, leading https://onelifesocial.com/story7420048/mini-antibodies-restore-p53-the-new-approach-for-tumor-treatment